Engineers Gate Manager’s Soleno Therapeutics SLNO Stock Holding History

Engineers Gate Manager’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-49,145	Closed	-$1.65M	–	2577
2026 Q1	$1.65M	Sell	49,145 -118,860	-71%	-$4.66M	0.02%	804
2025 Q4	$7.78M	Buy	+168,005	New	+$9.21M	0.09%	240
2024 Q4	–	Sell	-11,157	Closed	-$563K	–	2542
2024 Q3	$563K	Buy	+11,157	New	+$534K	0.01%	1320
2024 Q1	–	Sell	-7,702	Closed	-$310K	–	2273
2023 Q4	$310K	Buy	+7,702	New	+$219K	0.01%	1437

Engineers Gate Manager's SLNO Position: Q2 2026 in Review

Engineers Gate Manager sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 49,145 shares — an estimated $1.65M sold.

Engineers Gate Manager first reported a position in SLNO in Q4 2023 and held it in 4 quarters. The position peaked at $7.78M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Engineers Gate Manager reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 49,145 Soleno Therapeutics shares in Q2 2026, an estimated $1.65M.
Engineers Gate Manager first reported a position in Soleno Therapeutics in Q4 2023 and held it in 4 quarters.
Engineers Gate Manager's Soleno Therapeutics position peaked at $7.78M in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.